Carl Zeiss Meditec to Acquire IanTECH, Inc. to expand its portfolio in cataract surgery

Jena/Germany | 23 October 2018 | Carl Zeiss Meditec AG

ZEISS to enhance its portfolio of Surgical Ophthalmology solutions, further positioning the Company as a global innovation leader and solution provider in the full space of ophthalmology.

Carl Zeiss Meditec today announced it has entered into an agreement to acquire IanTECH. Headquartered in Reno, Nevada, IanTECH is a privately held company focused on technology solutions for micro-interventional cataract surgery.

Cataract surgery has been dependent on phaco technology for over 50 years. ZEISS believes that the market needs a fresh innovative approach in the field of phaco. IanTECH’s surgical technology is designed to change the future of managing cataracts. “We expect that IanTECH will complement our leading portfolio of equipment and consumables in cataract surgery, allowing us to offer physicians and patients a new standard of care,” says Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec. “The technology has the potential to simplify challenging cases, reduce risk to patients and further improve outcomes while being easy to train and adapt for surgeons.”

“We are pleased to bring the IanTECH team and technology into the ZEISS family,” states James V. Mazzo, Global President Ophthalmic Devices at Carl Zeiss Meditec.

“We look forward to joining ZEISS to combine our efforts in bringing superior technology to the market and we are pleased to align with the great culture and commitment at ZEISS,” adds Brian Walsh, CEO of IanTECH.

Press Contact

Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220-116
investors .meditec @zeiss .com

Laurie Ferguson
Head of Global Communications Ophthalmic Devices
Carl Zeiss Meditec Inc.
Phone: +1 925 560 5163
press .meditec @zeiss .com 

Brief Profile

Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With approximately 3,050 employees worldwide, the Group generated revenue of €1,280.9m in fiscal year 2017/18 (to 30 September).

The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 41 percent of Carl Zeiss Meditec AG’s shares are in free float. The remaining approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.

For more information visit our website at www.zeiss.com/med

Press Contact

Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220-116
investors .meditec @zeiss .com

Laurie Ferguson
Head of Global Communications Ophthalmic Devices
Carl Zeiss Meditec Inc.
Phone: +1 925 560 5163
press .meditec @zeiss .com 

Share
Further Articles

Quarterly Report December 2018

Carl Zeiss Meditec continues on growth course in fiscal year 2017/18

Both strategic business units make good contributions / Significant increases in Americas and APAC regions

Dec 7, 2018

ZEISS at AAO 2018

ZEISS Introduces New Advances in Astigmatism Management and Glaucoma Imaging

ZEISS Announces U.S. launch of Total Keratometry (TK®) for IOLMaster® 700, FDA Approval of Astigmatism indication for...

Oct 27, 2018

ZEISS TIVATO 700 and ZEISS EXTARO 300

Inventor of ENT surgical microscopes heralds digital age in visualization

TIVATO 700 and EXTARO 300 from ZEISS launch emerging workflow-enhancing augmentation concepts to ENT

Oct 7, 2018